876147-52-3

Basic information

• Product Name: (N-BOC-Morpholin-2-yl)Methyl phthaliMide
• Synonyms: tert-Butyl 2-((1,3-dioxoisoindolin-2-yl)Methyl)Morpholine-4-carboxylate;(N-BOC-Morpholin-2-yl)Methyl phthaliMide
• CAS NO: 876147-52-3
• Molecular Formula: C18H22N2O5
• Molecular Weight: 346.37768
• Mol File: 876147-52-3.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (N-BOC-Morpholin-2-yl)Methyl phthaliMide(CAS DataBase Reference)
• NIST Chemistry Reference: (N-BOC-Morpholin-2-yl)Methyl phthaliMide(876147-52-3)
• EPA Substance Registry System: (N-BOC-Morpholin-2-yl)Methyl phthaliMide(876147-52-3)

Safety Data

• Hazardous Substances Data: 876147-52-3(Hazardous Substances Data)

Usage

Description

(N-BOC-Morpholin-2-yl)Methyl phthaliMide is a chemical compound characterized by the molecular formula C18H20N2O5. It is a versatile reagent in organic synthesis, particularly for the preparation of pharmaceutical compounds. The presence of a BOC (tert-butoxycarbonyl) protective group attached to a morpholine ring allows for controlled reactivity in specific reactions. Furthermore, the phthalimide group in its structure is known for its anti-inflammatory and analgesic properties, which positions it as a promising candidate for drug development.

Uses

Used in Organic Synthesis:
(N-BOC-Morpholin-2-yl)Methyl phthaliMide is used as a reagent in organic synthesis for the preparation of various pharmaceutical compounds. Its BOC protective group and morpholine ring contribute to the controlled reactivity of the compound in specific reactions, making it a valuable component in the synthesis process.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (N-BOC-Morpholin-2-yl)Methyl phthaliMide is used as a potential candidate for drug development. The phthalimide group within the molecule has been found to exhibit anti-inflammatory and analgesic properties, which can be harnessed for the creation of new medications to address various health conditions.

Upstream product

• 136918-14-4 phthalimide 
• 135065-69-9 tert-butyl 2-(hydroxymethyl)morpholine-4-carboxylate 
• 34619-03-9 tert-butyldicarbonate 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 140645-53-0 2-(aminomethyl)morpholine-4-carboxylic acid tert-butyl ester 

Relevant articles and documents

AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME

Disclosed is a compound having a strong affinity to serotonin-4 receptors, which is useful as an enterokinesis-promoting agent or a digestive tract function-improving agent. Specifically, disclosed is a compound represented by Formula (1) or a pharmaceutically acceptable salt thereof. Also specifically disclosed is a pharmaceutical composition containing a compound represented by Formula (1) or a pharmaceutically acceptable salt thereof. [In Formula (1), Ar represents a group represented by Formula (Ar-1) or Formula (Ar-2).]

NOVEL CYCLIC AMINOBENZOIC ACID DERIVATIVE

The present invention relates to cyclic amino benzoic acid derivatives which are effective in therapy of lipid metabolism abnormality, diabetes and the like as a human peroxisome proliferators-activated receptor (PPAR) agonist, in particular, as an agonist against human PPARα isoform, and addition salts thereof, and pharmaceutical compositions containing these compounds. A cyclic amino benzoic acid derivative represented by the general formula (1) [wherein a ring Ar represents an aryl group which may have substituent, or the like; Y represents a C1-C4 alkylene, C2-C4 alkenylene, C2-C4 alkynylene, or the like; Z represents an oxygen atom, sulfur atom or - (CH2)n- (n represents 0,1 or 2) ; X represents a hydrogen atom, halogen atom, lower alkyl group which may be substituted with a halogen atom, or the like; R represents a hydrogen atom or lower alkyl group, and -COOR substitutes for an ortho position or metha position of binding position of ring W] or a pharmaceutically acceptable salt thereof.